Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 06 tags : Phase 3 save search
NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors
Published: 2021-07-06 (Crawled : 21:00) - globenewswire.com
NXTC | $1.67 6.37% 5.99% 62K
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: 1.65%
solid tumors phase 1 trial phase 2 phase 3
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma
Published: 2021-07-06 (Crawled : 20:00) - prnewswire.com
ONCS | $0.2772 25.59% 52M
|
Health Services
|
| O: 20.43%
H: 26.49%
C: 1.19%
collaboration phase 3 keytruda
Ascendis Pharma A/S Announces Target Enrollment Achieved in the Phase 3 PaTHway Trial of TransCon™ PTH (palopegteriparatide) in Adults with Hypoparathyroidism (HP) and Provides a Comprehensive Global Clinical Program Update
Published: 2021-07-06 (Crawled : 17:00) - biospace.com/
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: -1.57%
phase 3 trial enroll
Eiger BioPharmaceuticals Announces First Patients Dosed with Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Outpatients
Published: 2021-07-06 (Crawled : 17:00) - biospace.com/
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: -0.36%
H: 6.67%
C: 4.52%
covid biopharma phase 3
The Phase 3 ONWARD™ Trial Meets its Screening Target and Nears Enrollment Completion
Published: 2021-07-06 (Crawled : 14:00) - globenewswire.com
ADIL | $1.9 -12.44% -14.21% 310K
|
Health Technology
|
| O: 7.76%
H: 1.17%
C: -2.93%
phase 3 trial enroll
Iveric Bio Receives FDA Agreement Under Special Protocol Assessment (SPA) for GATHER2 Phase 3 Clinical Trial of Zimura® in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Published: 2021-07-06 (Crawled : 12:00) - biospace.com/
ISEE | $39.95 0.38% 0.38% 0
|
Health Technology
|
| O: 18.57%
H: 12.89%
C: 3.49%
fda phase 3 trial macular
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.